Eight Medicare plans have been recognized for high achievement or significant improvement in medication safety and appropriate use by the Pharmacy Quality Alliance.
The awards are based on CMS’ 2025 Medicare Part D Star Ratings, where only 1.3% of the 633 eligible plans qualified for recognition.
The Excellence in Quality Award recognizes Medicare Advantage Prescription Drug plans and Medicare Prescription Drug Plans. MAPDs are recognized for achieving at least a 4.5-star Part D summary rating and a 5-star rating on all five PQA measures used in the 2025 CMS Star Ratings. PDPs are recognized for achieving at least a 4.5-star Part D summary rating and at least a 4-star rating on all five PQA measures used in the 2025 CMS program.
The Quality Improvement Award recognizes MAPDs and PDPs that received a 5-star rating on the 2025 CMS Quality Improvement measure and the greatest combined improvement in star ratings from 2024 to 2025 on the five PQA medication measures used in the CMS program during this period.
Excellence in Quality Award – MAPDs:
- Alignment Healthcare
- Leon Health
Excellence in Quality Award – PDPs:
- Capital Blue Cross
- Pennsylvania Public School Employees Retirement System
- Excellus BlueCross BlueShield
- UPMC Health Plan
Quality Improvement Award – MAPDs:
- EmblemHealth
Quality Improvement Award – PDPs:
- Independent Health
